Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRCP with Secretin for Staging Chronic Pancreatitis in Pediatrics
NCT02869893Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Aug 2016
- Primary completion
- Apr 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of secretin in chronic pancreatitis (CP) and exocrine pancreatic insufficiency (EPI), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Total Secreted Fluid Volume as Measured by MR-PFT at 35 minutes. Started Aug 2016; status: completed.
02
Drugs
secretin
03
Conditions
chronic pancreatitis (CP)exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT02869893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02869893.